Suyama, Hisashi <br/><br/>
ERK activation and subsequent RB phosphorylation are important determinants of the sensitivity to paclitaxel in lung adenocarcinoma cells.  [electronic resource] 

 -  International journal of oncology  Jun 2004 
 - 1499-504 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article 
<br/><br/><label>ISSN: </label>1019-6439 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adenocarcinoma--drug therapy<br/>Antineoplastic Agents, Phytogenic--pharmacology<br/>Drug Resistance, Neoplasm<br/>Enzyme Activation--drug effects<br/>Enzyme Inhibitors--pharmacology<br/>Extracellular Signal-Regulated MAP Kinases--metabolism<br/>G1 Phase--drug effects<br/>Gene Expression Regulation, Neoplastic<br/>Humans<br/>Lung Neoplasms--drug therapy<br/>Paclitaxel--pharmacology<br/>Phosphorylation--drug effects<br/>Retinoblastoma Protein--drug effects<br/>Tumor Cells, Cultured